Shrader & Associates news

A development in early mesothelioma detection has the potential to improve the diagnosis process for patients. In support of its clients who are affected by this disease, Shrader & Associates, LLP is excited about the “electronic nose,”—a test developed by researchers in Italy and the Netherlands that analyzes breath samples to detect compounds indicating mesothelioma.

Traditionally, mesothelioma diagnosis requires a biopsy